Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Hematology|May 14, 2008
Pharmacokinetics-based optimal dose-exploration of mycophenolate mofetil in allogeneic hematopoietic stem cell transplantationAtsuo Okamura, Motohiro Yamamori, Manabu Shimoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2021
[A Case of Dermatitis Caused by Metronidazole Gel That Needed to Be Differentiated from Breast Cancer Skin Metastasis]Sae Ishihara, Shinichiro Kashiwagi, Yuka Asano, et al.
Cells|June 10, 2023
Mitochondrial Transfer to Host Cells from Ex Vivo Expanded Donor Hematopoietic Stem CellsHiroki Kawano, Yuko Kawano, Chen Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancerAtsushi Horiike, Kengo Takeuchi, Takeshi Uenami, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 20, 2009
[Defibrotide therapy for patients with sinusoidal obstruction syndrome after hematopoietic stem cell transplantation]Kimikazu Yakushijin, Atsuo Okamura, Kanako Ono, et al.
Blood|February 6, 2019
Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosisKanako Wakahashi, Kentaro Minagawa, Yuko Kawano, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2024
Discovery of a potent, orally available furopyridine derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitorShuichi Hagihara, Kouhei Ishizawa, Manami Kikuchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 2014
[Thrombopoietin receptor agonists administration for acute exacerbation of chronic idiopathic thrombocytopenic purpura and subsequent anticoagulant therapy for accompanying deep venous thrombosis of the lower limbs]Hiroki Kawano, Tomohide Suzuki, Shinichi Ishii, et al.
Haematologica|February 4, 2021
Mobilization efficiency is critically regulated by fat via marrow PPARδTomohide Suzuki, Shinichi Ishii, Masakazu Shinohara, et al.
Arthritis Research & Therapy|September 1, 2022
Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosisMasahiro Kondo, Tsuyoshi Suzuki, Yuko Kawano, et al.
Pageof 6